Nat Immunol (2017) 18:48898
Restoring Impaired Associative Learning In a recent study in Nature Metabolism , Hanssen and colleagues showed that a GLP-1 drug (liraglutide), in a small trial (N=24 participants) of people with insulin resistance, with a single-blind, randomized, placebo-controlled crossover design, with functional brain MRIs, that 1 dose normalized impaired learning of sensory associations, supporting that metabolic signals profoundly influence neuronal processing. Reduced Alcohol Drinking and Potential Anti-addiction Drug Effects In the experimental model, Chuong and colleagues published in JCI the impact of GLP-1 drugs to inhibit alcohol intake
Combination of everolimus with exemestrane is an effective treatment for ER + /ErbB2 - breast cancer
Anwendungsprofil in der Behandlungskabine L-Carnitine richtet sich an Fachpersonal, das einen grundlegenden Krperwirkstoff fr Protokolle gegen Cellulite und lokale Fettdepots sucht
The knee-replacement consent was torn up, her CPAP sat unplugged, and her blood pressure rivaled her college-athlete days
Liraglutide was the first injectable daily GLP-1 receptor agonist that was approved by the FDA for weight loss in 2014